Most companies treat Article 11 as a tax-cutting tool. A strategic reading turns it into a mechanism for converting research spending into a durable financial asset.
When research projects are aligned with real business needs, the exemption stops being a one-off discount and becomes a recoverable investment in the organization’s technological capacity.
The key to leverage is rigorous documentation and tying every unit of spend to a defined technology outcome — exactly what Novaco operationalizes through its four-stage model.